Pfizer Inc., US7170811035

Pfizer stock pre-market at EUR 24.51: plus 0.41 percent

Published on 10/07/2026 at 08:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock is at EUR 24.51 in pre-market trading at Lang & Schwarz, up 0.41 percent versus the EUR 24.41 prior close on October 6, 2026.

Extreme Nahaufnahme unbeschrifteter weißer Tabletten und Kapseln, Symbolbild für Pfizer Inc
Makroaufnahme unbeschrifteter Tabletten und Kapseln veranschaulicht das Kerngeschäft von Pfizer Inc., ISIN US7170811035, Pharmaindustrie, Illustration mit AI erstellt.

Pfizer stock is at EUR 24.51 in pre-market trading at Lang & Schwarz at 8:19 a.m. CEST on October 7, 2026. The price is up 0.41 percent, or EUR 0.10, versus the EUR 24.41 prior close at Lang & Schwarz on October 6, 2026.

Pre-market price

The Lang & Schwarz bid was EUR 24.45 and the ask was EUR 24.57. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Pfizer stock.

Dividend declaration

In a Business Wire release dated October 6, 2026, Pfizer Inc. said its board declared a USD 0.43 fourth-quarter 2026 dividend on the company’s common stock. The dividend is payable December 7, 2026, to shareholders of record at the close of business on November 6, 2026. Pfizer said the payment will be its 352nd consecutive quarterly dividend.

Upcoming oncology presentations

Pfizer plans to present data from 45 company-sponsored, investigator-sponsored and collaborative research abstracts at the European Society for Medical Oncology Congress in Madrid from October 23 to October 27, 2026, according to a Business Wire release dated September 28. The program includes 11 oral presentations covering established medicines and late-stage pipeline candidates in breast, genitourinary and lung cancers.

Disclaimer...

en | US7170811035 | PFIZER INC. | boerse | 70252444 | bgmi